MoneyWorks4Me

Dr. Reddy's expecting overall performance to be quite volatile in current fiscal

06 Jul 2020 Evaluate
Dr. Reddy's Laboratories is expecting its overall performance to be quite volatile in the current fiscal with uncertainties related to COVID-19 set to increase during the period. As per the company, overall, there was no major impact of the pandemic during the last fiscal, including the fourth quarter.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..